Sök i kliniska prövningar för: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belg
Totalt 15 resultat
-
Hui ZhuangGuangxi Center for Disease Control and PreventionAvslutadImmunsvar | Hepatit B | SeroprevalensKina
-
Merck Sharp & Dohme LLCAvslutad
-
Merck Sharp & Dohme LLCAvslutad
-
Universidad de ValparaisoGlaxoSmithKline; Roche Pharma AG; Aclin LaboratoryAvslutad
-
GlaxoSmithKlineRegion of Wallonia; Public Private Partnership with Institute for Medical...Avslutad
-
Dynavax Technologies CorporationAvslutadHepatit BFörenta staterna
-
GlaxoSmithKlineAvslutad
-
GlaxoSmithKlineAvslutad
-
Tehran University of Medical SciencesAvslutad
-
HIV Vaccine Trials NetworkAvslutad
-
Quaid-e-Azam UniversityHealth Services Academy, Islamabad, Pakistan; Medical Research Council,...Avslutad
-
National Institute of Allergy and Infectious Diseases...Avslutad
-
University of North Carolina, Chapel HillAlbert Einstein College of Medicine; Abbott; Doris Duke Charitable Foundation och andra samarbetspartnersRekryteringHepatit B | Vertikal överföring av infektionssjukdomarKongo, Demokratiska republiken
-
National Institute of Allergy and Infectious Diseases...AvslutadHIV-infektionerFörenta staterna, Australien
-
French National Agency for Research on AIDS and...GlaxoSmithKlineAvslutad